UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 11, 2010
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
| DELAWARE | 1-11083 | 04-2695240 |
| (State or other | (Commission | (IRS employer |
| jurisdiction of | file number) | identification no.) |
| incorporation) |
| One Boston Scientific Place, Natick, Massachusetts | 01760-1537 |
| (Address of principal executive offices) | (Zip code) |
Registrant’s telephone number, including area code: (508) 650-8000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 8.01. | OTHER EVENTS. |
On August 11, 2010, Boston Scientific Corporation announced that it has been notified by the U.S. Food and Drug Administration that all issues cited in Boston Scientific Corporation’s corporate warning letter have been resolved.
A copy of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein.
| ITEM 9.01. | FINANCIAL STATEMENTS AND EXHIBITS |
(d) Exhibits
Exhibit Number | Description | |
| 99.1 | Press Release dated August 11, 2010 issued by Boston Scientific Corporation. |
- 2 -
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BOSTON SCIENTIFIC CORPORATION | |||
| Date: August 11, 2010 | By: | /s/ Timothy A. Pratt | |
| Timothy A. Pratt | |||
| Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | |||
- 3 -
INDEX TO EXHIBITS
Exhibit Number | Description | |
| 99.1 | Press Release dated August 11, 2010 issued by Boston Scientific Corporation. |
- 4 -